Your browser doesn't support javascript.
loading
Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes.
Hitti-Malin, Rebekkah J; Panneman, Daan M; Corradi, Zelia; Boonen, Erica G M; Astuti, Galuh; Dhaenens, Claire-Marie; Stöhr, Heidi; Weber, Bernhard H F; Sharon, Dror; Banin, Eyal; Karali, Marianthi; Banfi, Sandro; Ben-Yosef, Tamar; Glavac, Damjan; Farrar, G Jane; Ayuso, Carmen; Liskova, Petra; Dudakova, Lubica; Vajter, Marie; Oldak, Monika; Szaflik, Jacek P; Matynia, Anna; Gorin, Michael B; Kämpjärvi, Kati; Bauwens, Miriam; De Baere, Elfride; Hoyng, Carel B; Li, Catherina H Z; Klaver, Caroline C W; Inglehearn, Chris F; Fujinami, Kaoru; Rivolta, Carlo; Allikmets, Rando; Zernant, Jana; Lee, Winston; Podhajcer, Osvaldo L; Fakin, Ana; Sajovic, Jana; AlTalbishi, Alaa; Valeina, Sandra; Taurina, Gita; Vincent, Andrea L; Roberts, Lisa; Ramesar, Raj; Sartor, Giovanna; Luppi, Elena; Downes, Susan M; van den Born, L Ingeborgh; McLaren, Terri L; De Roach, John N.
  • Hitti-Malin RJ; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Panneman DM; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Corradi Z; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Boonen EGM; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Astuti G; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Dhaenens CM; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France.
  • Stöhr H; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.
  • Weber BHF; Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.
  • Sharon D; Institute of Clinical Human Genetics, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Banin E; Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
  • Karali M; Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
  • Banfi S; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy.
  • Ben-Yosef T; Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania 'Luigi Vanvitelli', 80131 Naples, Italy.
  • Glavac D; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy.
  • Farrar GJ; Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania 'Luigi Vanvitelli', 80131 Naples, Italy.
  • Ayuso C; Telethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy.
  • Liskova P; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel.
  • Dudakova L; Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • Vajter M; Center for Human Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.
  • Oldak M; The School of Genetics and Microbiology, The University of Dublin Trinity College, D02 VF25 Dublin, Ireland.
  • Szaflik JP; Department of Genetics, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28049 Madrid, Spain.
  • Matynia A; Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Gorin MB; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
  • Kämpjärvi K; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
  • Bauwens M; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
  • De Baere E; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
  • Hoyng CB; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
  • Li CHZ; Department of Histology and Embryology, Medical University of Warsaw, 02-004 Warsaw, Poland.
  • Klaver CCW; Department of Ophthalmology, Medical University of Warsaw, SPKSO Ophthalmic University Hospital, 03-709 Warsaw, Poland.
  • Inglehearn CF; College of Optometry, University of Houston, Houston, TX 77004, USA.
  • Fujinami K; Jules Stein Eye Institute, Los Angeles, CA 90095, USA.
  • Rivolta C; Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA 90095, USA.
  • Allikmets R; Jules Stein Eye Institute, Los Angeles, CA 90095, USA.
  • Zernant J; Blueprint Genetics, 02150 Espoo, Finland.
  • Lee W; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Podhajcer OL; Center for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium.
  • Fakin A; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Sajovic J; Center for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium.
  • AlTalbishi A; Department of Ophthalmology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Valeina S; Department of Ophthalmology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Taurina G; Department of Ophthalmology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Vincent AL; Division of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds LS9 7TF, UK.
  • Roberts L; Department of Ophthalmology, The Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Ramesar R; Institute of Molecular and Clinical Ophthalmology Basel, 4031 Basel, Switzerland.
  • Sartor G; Department of Ophthalmology, Columbia University, New York, NY 10027, USA.
  • Luppi E; Department of Pathology & Cell Biology, Columbia University, New York, NY 10027, USA.
  • Downes SM; Department of Ophthalmology, Columbia University, New York, NY 10027, USA.
  • van den Born LI; Department of Ophthalmology, Columbia University, New York, NY 10027, USA.
  • McLaren TL; Laboratorio de Terapia Molecular y Celular (Genocan), Fundación Instituto Leloir, CONICET, Buenos Aires 1405, Argentina.
  • De Roach JN; Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Biomolecules ; 14(3)2024 Mar 19.
Article en En | MEDLINE | ID: mdl-38540785
ABSTRACT
Inherited macular dystrophies (iMDs) are a group of genetic disorders, which affect the central region of the retina. To investigate the genetic basis of iMDs, we used single-molecule Molecular Inversion Probes to sequence 105 maculopathy-associated genes in 1352 patients diagnosed with iMDs. Within this cohort, 39.8% of patients were considered genetically explained by 460 different variants in 49 distinct genes of which 73 were novel variants, with some affecting splicing. The top five most frequent causative genes were ABCA4 (37.2%), PRPH2 (6.7%), CDHR1 (6.1%), PROM1 (4.3%) and RP1L1 (3.1%). Interestingly, variants with incomplete penetrance were revealed in almost one-third of patients considered solved (28.1%), and therefore, a proportion of patients may not be explained solely by the variants reported. This includes eight previously reported variants with incomplete penetrance in addition to CDHR1c.783G>A and CNGB3c.1208G>A. Notably, segregation analysis was not routinely performed for variant phasing-a limitation, which may also impact the overall diagnostic yield. The relatively high proportion of probands without any putative causal variant (60.2%) highlights the need to explore variants with incomplete penetrance, the potential modifiers of disease and the genetic overlap between iMDs and age-related macular degeneration. Our results provide valuable insights into the genetic landscape of iMDs and warrant future exploration to determine the involvement of other maculopathy genes.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Degeneración Macular Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Degeneración Macular Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article